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Mammalian D-type cyclins are growth factor-regulated, elayed early response genes that are presumed to 
control progression through the G1 phase of the cell cycle by governing the activity of cyclin-dependent 
kinases (cdks). Overexpression of mouse cyclin D1 in serum-stimulated mouse NIH-3T3 and rat-2 fibroblasts 
increased their rates of G o to S- and GI- to S-phase transit by several hours, leading to an equivalent 
contraction of their mean cell generation times. Although such cells remained contact inhibited and 
anchorage dependent, hey manifested a reduced serum requirement for growth and were smaller in size than 
their normal counterparts. Ectopic expression of cyclin D2 in rodent fibroblasts, either alone or together with 
exogenous cdk4, shortened their G o- to S-phase interval and reduced their serum dependency, but cyclin D2 
alone did not alter cell size significantly. When cells were microinjected uring the G 1 interval with a 
monoclonal antibody specifically reactive to cyclin D1, parental rodent fibroblasts and derivatives 
overexpressing this cyclin were inhibited from entering S phase, but cells injected near the G1/S phase 
transition were refractory to antibody-induced growth suppression. Thus, cyclin D1, and most likely D2, are 
rate limiting for Glprogression. 
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The decision of eukaryotic ells to replicate their chro- 
mosomal DNA is made late in the first gap phase (G~) of 
the cell cycle. In the budding yeast Saccharomyces cer- 
evisiae, this transition is governed by the accumulation 
of G~ cyclins encoded by three CLN genes and their cat- 
alytic subunit, the cyclin-dependent kinase (cdk) 
p34 cDC28 (or its equivalent, p34 cat2, in the fission yeast, 
Schizosaccharomyces pombe). The Gl-specific activities 
of the holoenzymes are rate limiting for passage through 
Start (Hartwell 1974), a point late in G~ at which envi- 
ronmental signals converge on the cell cycle clock to 
drive entry into S phase (for review, see Reed 1991). Cell 
size, presumed to be regulated by available nutrients, is 
critical for Start (Pringle and Hartwell 1981), and because 
both dominant and loss-of-function mutations in CLN 
genes reciprocally affect this parameter, CLN function 
likely determines when cell size is sufficient for Start to 
occur (Sudbery et al. 1980; Cross 1988; Nash et al. 1988; 
Hadwiger et al. 1989; Richardson et al. 19891. Con- 
versely, the mating pheromone, a-factor, arrests G~ pro- 
gression in budding yeast by triggering signals that neg- 
atively regulate CLN function (Cross 1988; Nash et al. 
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1988; Chang and Herskowitz 1990; Elion et al. 1990; 
Wittenberg et al. 1990). The activity of any one of three 
CLN genes is sufficient for cell growth, but mutations in 
all three are necessary to induce G1 arrest at the same 
position in the cell cycle as mutants defective in CDC28 
(Richardson et al. 1989). CLN genes are differentially reg- 
ulated, and only the CLN1 and CLN2 RNAs, for exam- 
ple, vary in abundance during the cell cycle, peaking dur- 
ing G1 (Wittenberg et al. 1990). Execution of Start occurs 
before the onset of DNA synthesis, and mutations in 
genes other than the CLNs or CDC28 can arrest G~ pro- 
gression after Start but before the G~/S transition (Prin- 
gle and Hartwell 1981; Hennessy and Botstein 1991; 
Johnston et al. 1991). It remains possible that a separate 
requirement for CDC28/cdc2 at the G~/S transition has 
not been observed in yeast because of the short time 
interval separating Start from the beginning of S phase. 
In animal cells, passage through a late G~ restriction 
point (R) analogous to Start defines the time at which 
cells no longer require growth factors to enter S phase, 
which occurs several hours later (Pardee 1989). An accu- 
mulation of unstable proteins is required to pass the R 
point, and it is reasonable to speculate that such proteins 
might be mammalian G1 cyclins, which could regulate 
one or more cyclin-dependent kinases (cdks) to drive cell 
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cycle progression in a rate-limiting manner. Cyclins 
identical to CLNs have not been isolated from mamma- 
lian cells, but several such proteins, including three 
D-type cyclins and cyclin E (Koff et al. 1991; Lew et al. 
1991; Matsushime t al. 1991a; Motokura et al. 1991; 
Xiong et al. 1991), now appear likely to regulate vents 
late in G1. Cyclin E expression is periodic and peaks at 
the G1/S transition (Lew et al. 1991), and it regulates the 
activity of cdk2 (Dulic et al. 1992; Koff et al. 1992), a 
cyclin-dependent kinase whose activity is necessary for 
S-phase entry (Pagano et al. 1993; Tsai et al. 1993). Fi- 
broblasts engineered to overexpress cyclin E were re- 
cently found to exhibit a shortened G1 interval, de- 
creased cell size, and a reduced serum requirement for 
the G1/S transition, providing the first direct evidence 
that this cyclin can be rate-limiting for G1 progression i  
mammalian cells (Ohtsubo and Roberts 1993). 
Data that D-type cyclins can regulate G 1 progression 
have so far been largely inferential. D-type cyclins gen- 
erally appear earlier in G1 than cyclin E, and they are 
differentially expressed in various cell lineages in a 
highly growth factor-dependent manner (Matsushime t 
al. 1991a, b; Cocks et al. 1992; Won et al. 1992; Ajchen- 
baum et al. 1993). The D-type cyclins interact with an 
atypical catalytic partner, cdk4 (Matsushime t al. 1992; 
Kato et al. 1993), but at least some of them can associate 
with other cdks, including cdk2 and cdk5 (Xiong et al. 
1992; Ewen et al. 1993). Disruption of cyclin D1 function 
by microinjection of antisense plasmids or antibodies 
into serum-stimulated fibroblasts during mid-G1 can 
prevent their entry into S phase, but microinjections 
near the G~/S boundary are without effect (Baldin et al. 
1993). Here, we show that overexpression of different 
D-type cyclins in rodent fibroblasts can shorten their G1 
interval, thereby providing direct evidence that they can 
positively regulate G1 progression. 
Results 
Derivation of cell lines overexpressing D-type cyclins 
Initially, we attempted to express exogenous murine cy- 
clin D 1 cDNA in rat-2 or mouse NIH-3T3 fibroblasts by 
use of retroviral vectors containing a selectable marker 
(neo) that confers resistance to the antibiotic, G418. Cy- 
clin D1 cDNA was cloned 5' to the neo gene immedi- 
ately downstream of viral long terminal repeat (LTR) 
promoter/enhancers derived either from the Moloney 
murine leukemia virus (MuLV) [pZipSV(X)I vector] or 
the myeloproliferative sarcoma virus (pZEN-tkneo vec- 
tor), respectively. Alternatively, we used a vector 
(pBC140) in which neo expression is driven by the retro- 
viral 5' LTR and cyclin D1 by an internal cytomegalovi- 
rus (CMV) promoter. Many fewer G418-resistant colo- 
nies arose in cultures transfected with the cyclin D1- 
containing vectors than with the naked control vectors 
(Table 1), and pooled surviving colonies failed to detect- 
ably overexpress cyclin D1 protein. 
Cyclin D 1 cDNA was then cloned into a Moloney mu- 
Table 1. Transfection efficiency of cyclin D expression 
vectors in rat-2 fibroblasts 
Vector plasmid 
Transfection efficiency 
(neo-resistant 
colonies/~g DNAI 
pZIPSV(X)I 1.1 x 104 
pZIPSV(X)I-D1 1.0 x 102 
pZEN 1.9 x 104 
pZEN-D1 4.4 x 102 
pBC140 9.0 x 103 
pBC140-D1 1.6 x 102 
pCOS-MSV-tkneo 9.1 x 103 
pCOS-MSV-tkneo-D1 6.0 x 101 
pRc/RSV-neo 9.1 x 103 
pRc/RSV-neo--D1 (rat-D1 I~ 9.0 x 103 
pRc/RSV-neo 6.0 x 104 
pRc/RSV-neo-D1 (rat-D1 hi) 2.6 x 104 
Cells transfected with the indicated vector plasmids containing 
the neomycin resistance gene were selected in G418, and colo- 
nies of resistant cells were numerated 3 weeks later. (-D1) 
Vectors containing cyclin D1 cDNA. The transfection experi- 
ments giving rise to pooled populations expressing relatively 
low (rat-D1 l~ or high (rat-D1 hi) levels of cyclin D1 are indi- 
cated in parentheses. 
rine sarcoma virus-based vector plasmid containing the 
SV40 replication origin (pCOS-MSV-tkneo), which en- 
ables its amplification in monkey cells expressing T an- 
tigen. Following transfection into a Cos packaging cell 
line engineered to express retroviral genes necessary for 
virion production, viruses harvested from the culture su- 
pernatants 48-72 hr later were titered on NIH-3T3 cells. 
In three independent transfection experiments using the 
vector alone, the average titer of released viruses able to 
confer G418-resistance in NIH-3T3 cells was 2.5 x 10 6 
colony-forming units (cfu) per milliliter of culture super- 
natant, but cells transfected with the cyclin Dl-contain- 
ing vector yielded only 3.8 x 104 cfu per milliliter. Di- 
rect transfection of rat-2 cells with this cyclin D 1 vector 
plasmid also generated many fewer G418-resistant colo- 
nies than cells transfected with the parental vector (Ta- 
ble 1), and again, infected or transfected G418-resistant 
fibroblasts did not detectably express elevated levels of 
cyclin D1 protein. Thus, there appeared to be a strong 
selection against he establishment of cell lines able to 
overexpress exogenous cyclin D1. Similar difficulties 
were encountered with MuLV-based vectors containing 
the cyclin D2 and D3 cDNAs. 
We reasoned that if high levels of exogenous cyclin D 
synthesis were incompatible with cell growth or viabil- 
ity, the use of weak or inducible promoters might enable 
us to circumvent this problem. After t ansfection ofrat-2 
cells with a vector in which cyclin D1 gene expression 
was driven by the avian Rous arcoma virus promoter 
(pRc/RSV-neo), no significant reduction in the number 
of G418-resistant colonies was observed as compared 
with cells transfected with a control vector (Table 1). 
Following metabolic labeling with [3SS]methionine and 
quantitative immunoprecipitation with rabbit antise- 
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rum to cyclin D1, the pooled neo-resistant populations 
(designated rat-D11~ were found to synthesize approxi- 
mately threefold more of the 36-kD cyclin D1 protein 
(p36 TM) than that normally produced in parental rat-2 
cells {Fig. 1A, cf. lanes 8 and 2). Cyclin D1 mRNA and 
Figure 1. Expression of D-type cyclins in transfected cell lines. 
Rat-2 {A)and NIH-3T3 {B) cell lines were metabolically labeled 
with [3SS]methionine, and 125 txg of protein per lysate was pre- 
cipitated with the antisera indicated below the panels, dena- 
tured, and separated on polyacrylamide g ls. In A and B, lanes 
1-4 illustrate the relative levels of synthesis of cdk4 and D-type 
cyclins in parental, untransfected cell lines. Lanes 5-10 in A 
show results with six independently derived rat-2 cell lines 
transfected with the cyclin D genes indicated above each lane 
and immunoprecipitated with the cognate antisera. Lanes 5-7 
in B show similar results for three NIH-3T3 derivatives, 
whereas lanes 8 and 9 show results of immunoprecipitations 
performed with anti-cdk4 or anti-cyclin D2 with a single cell 
line cotransfected with both genes. All autoradiographic expo- 
sure times were 2 days. Immunoblotting analysis (C) was used 
to quantitate steady-state levels of cyclin D and cdk4 in the 
transfected cell lines. Equal mounts of protein from cell lysates 
prepared from the cell lines designated above th panels were 
precipitated with antisera to cyclin D 1 (top), cyclin D2 {middle), 
or cdk4 (bottom). Immune complexes were separated on dena- 
turing gels, transferred to nitrocellulose, and immunoblotted 
with cognate antisera. The autoradiographic exposure tim s 
were 2 days for the cyclins and 7 days for cdk4. 
protein were not detected in serum-starved parental fi- 
broblasts {also see Won et al. 1992; Baldin et al. 1993); 
but when quiescent cells were stimulated to re-enter the 
cell cycle, cyclin D1 protein was induced by 3 hr and 
accumulated to maximal evels by 7 hr after serum ad- 
dition. In contrast, cells transfected with the cyclin D1 
gene constitutively synthesized elevated levels of the 
protein throughout the cell cycle, as determined by se- 
quential immunoprecipitation and immunoblotting 
{data not shown). 
Parental rat-2 cells normally synthesize no detectable 
cyclin D2 and very low levels of cyclin D3 {Fig. 1A, lanes 
3,41, but enforced expression of each was also achieved 
by use of pRc/RSV-neo vectors containing these cDNAs 
(Fig 1A, lanes 9,10). The three D-type cyclins can be dis- 
tinguished by their electrophoretic mobilities on dena- 
turing gels {lanes 8-10), as predicted from small differ- 
ences in their molecular masses [Matsushime t al. 
1991b). Although the rabbit antisera to bacterially pro- 
duced cyclins D1 and D2 reciprocally cross-react with 
one another, the antiserum to cyclin D2 reacts preferen- 
tially with the cognate protein and did not quantitatively 
coprecipitate ndogenous cyclin D1 under the condi- 
tions used [lane 91. In contrast, the antiserum to cyclin 
D3 does not cross-react with cyclins D1 or D2 (Matsu- 
shime et al. 1992). With optimized transfection condi- 
tions, 5-10-fold higher levels of synthesis of the exoge- 
nous mouse cyclins D1 and D2 (rat-D1 hi and rat-D2 hi) 
were realized (Fig. 1A, lanes 5,6). Even under the best 
circumstances, however, the levels of enforced cyclin D3 
synthesis remained relatively low (lane 7). 
Rat-2 cells express relatively high levels of cdk4 (Fig. 
1A, lane 1), the major catalytic partner of cyclin D1, and 
most  p34 cdk4 coprecipitated in immune complexes with 
cyclin D 1 when the latter was highly overexpressed (lane 
5). Cyclin D2 also functionally interacts with cdk4 (Mat- 
sushime et al. 1992; Kato et al. 1993), and although it 
was not readily observed in anti-D2 precipitates from 
metabolically labeled cells (lane 6), immunoblotting of
the denatured D2 immunoprecipitates with antiserum 
to cdk4 revealed its presence (data not shown). The latter 
method is more sensitive in detecting p34 cdk4 in such 
complexes, because unlike the cyclins, which have a 
short half-life (t~/2 = 20 min), p34 cdk4 is relatively stable 
(t~/2 > 4 hr), and only a fraction of the pool incorpo- 
rates [3SS]methionine during a 1-hr labeling period (Mat- 
sushime et al. 1992). Nonetheless, we do not know 
whether the observed ifferences in the amounts of cdk4 
detected in complexes with cyclins D1 and D2 were at- 
tributable to the higher levels of ectopically expressed 
D1 versus D2 (of. lanes 5 and 6) or reflect physiologic 
differences in their ability to stably interact with this 
catalytic subunit. 
By use of the same vector, we were also able to confer 
increased expression of the three D-type cyclins in NIH- 
3T3 ceils (Fig. 1B, lanes 5-7), which normally express 
cyclins D1 and D2, but not D3 {lanes 2-4). As for rat-2 
cells, enforced synthesis of ectopic cyclin D3 was nom- 
inal, whereas 5- to 10-fold increases in cyclin D1 and D2 
production were observed. NIH-3T3 cells express lower 
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levels of cdk4 than rat-2 fibroblasts (Fig. 1, cf. A and B, 
lanes 1), but cotransfection of NIH-3T3 cells with pRc/ 
RSV-neo vectors encoding cyclin D2 and cdk4 gave rise 
to cells overexpressing both proteins (Fig. 1B, lanes 8,9). 
The latter cells also expressed approximately two- to 
threefold more cyclin D2 (lane 91 than those transfected 
with the cyclin D2 gene alone (lane 6). In parallel trans- 
fections, we did not derive stable NIH-3T3 transfor- 
mants significantly overexpressing only cdk4. As for the 
rat-2 derivatives, anti-D1 precipitates contained more 
cdk4 than those prepared with anti-D2 (cf. lane 5 with 
lanes 6 and 9). 
Because D-type cyclins are highly unstable proteins 
(Matsushime t al. 1991a, 1992), immunoblotting was 
used to estimate their relative steady-state levels in 
asynchronously dividing fibroblasts (Fig. 1C). In agree- 
ment with metabolic labeling studies, the levels of cy- 
clins D1 and D2 in cell lines transfected with the corre- 
sponding enes were increased 5- to 10-fold over those in 
their parental counterparts. These experiments also con- 
firmed that rat-2 cells express more  p34 cdk4 than mouse 
NIH-3T3 fibroblasts and that cotransfection ofcyclin D2 
and cdk4 into the latter cells led to a three- to fourfold 
increase in their cdk4 levels. NIH-3T3 cells overexpress- 
ing cyclin D2 paradoxically exhibited a somewhat re- 
duced level of endogenous D 1 than that in parental con- 
trols [Fig. 1C, lanes 4,6 (top)], but cells transfected with 
both cyclin D2 and cdk4 showed no reduction in their 
D1 levels [lane 7, (top)]. Consistent with our inability to 
efficiently enforce cyclin D3 expression in rodent fibro- 
blasts (Fig. 1A, B), we were unable to document i s over- 
expression in the cognate transfectants by immunoblot- 
ting techniques (data not shown). Subsequent studies 
therefore focused on cell lines overexpressing cyclins D 1 
and D2. 
Given our initial difficulties in achieving stable ec- 
topic D-type cyclin expression from what we assume are 
strong mammalian viral promoters (Table 1), it is for- 
mally possible that the cells transfected with the D-type 
cyclin-containing pRc/RSV-neo vectors had sustained 
secondary mutations that facilitated cyclin overexpres- 
sion. This seems unlikely for several reasons. First, no 
significant selective pressure against exogenous D-type 
cyclin expression was observed when pRc/RSV-neo vec- 
tors were used (Table 1). Second, because numerous 
G418-resistant colonies were pooled from each transfec- 
tion experiment, each cell population represented a prod- 
uct of multiple vector-cell interactions, as confirmed by 
Southern blotting with a neo probe (see Materials and 
methods). Third, results similar to those using pRc/ 
RSV-neo were obtained following transfection of rat-2 
cells with an expression vector containing an artificial 
promoter composed of reiterated heavy metal response 
elements (Kato et al. 1989). In the absence of added heavy 
metals, cyclin D1 was modestly overexpressed and was 
further induced twofold by addition of zinc and cad- 
mium to the culture medium {data not shown). Al- 
though the latter manipulations failed to provide a non- 
leaky system for studying conditional cyclin D expres- 
sion, the results argue that pRc/RSV-neo is not unique 
in facilitating ectopic D-type cyclin expression in rodent 
fibroblasts. 
Overexpression f cyclin D1 in fibroblasts hortens 
their G1 interval 
To determine whether cyclin D1 could accelerate G1 
progression, parental rat-2 cells, as well as transfected 
populations expressing low (Fig. 1A, lane 8) or high (Fig. 
1A, lane 5) levels of cyclin D1, were arrested in meta- 
phase with the microtubule inhibitor, nocodazole, and 
their rates of transit through the cell cycle were mea- 
sured after reversal of the mitotic block. To obtain a high 
degree of synchrony and reduce potential drug toxicity, 
subconfluent cells starved for 36 hr in medium contain- 
ing 0.1% fetal calf serum (FCS) were released from Go in 
medium containing 10% FCS, and after 15-17 hr of se- 
rum stimulation, cells that had progressed into the late S 
and early G~ phases were treated with a minimum effec- 
tive dose of nocodazole for an additional 5 hr. Arrested 
cells exhibited a4N DNA content {Fig. 2; Table 2, 0 hr), 
and the vast majority synchronously entered G1 after 
nocodazole was removed (Fig. 2, 4.5 hr). However, -10% 
of the cells did not revert to a 2N DNA content after 
nocodazole release (Table 2), reflecting some toxicity of 
the drug. Moreover, not all 2N cells were able to traverse 
G~ after release, and some cell death was observed uring 
the course of the experiment. 
In spite of these difficulties, >60% of parental rat-2 
cells and cyclin D1 overexpressers progressed through 
the cell cycle. Parental rat-2 cells entered S phase be- 
tween 10 and 12 hr after nocodazole release, whereas 
those expressing high levels of cyclin D1 (rat-D1 hi) ex- 
hibited a significantly shortened G~ interval and entered 
S phase after only a 6-to 8-hr delay (Fig. 2; Table 2). Cells 
expressing lower levels of cyclin D 1 (rat-D 11~ yielded an 
intermediate r sult, entering Sphase 8-10 hr after rever- 
sal of the nocodazole blockade. Parental rat-2 cells com- 
pleted the cell cycle and were maximally mitotic -20 hr 
later (as determined by microscopic enumeration ofmet- 
aphase chromosome spreads), but the generation time of 
cells overexpressing cyclin D1 was shortened by 2 (rat- 
D11~ to 3 (rat-D1 hi) hr, reflecting their respectively ab- 
breviated G~ intervals. Therefore, premature ntry of the 
cells into S phase did not result in a compensatory pro- 
longation of the DNA replicative phase. G418-resistent 
rat-2 cells transfected with a vector expressing neo alone 
yielded results indistinguishable from those of untrans- 
fected cells. A similar 2.5-hr contraction of the G1 inter- 
val relative to vector-transfected controls was observed 
using NIH-3T3 cells overexpressing cyclin D1 (data not 
shown). 
Although Figure 2 and Table 2 illustrate only a single 
representative data set for three cell lines, the compara- 
tive results were highly reproducible and significant (see 
Analysis of cell cycle kinetics, Materials and methods). 
That is, rat-2 or NIH-3T3 cells overexpressing high lev- 
els of cyclin D1 always exhibited equivalently faster 
rates of entry into S phase (2.4 -- 0.6 hr) and mitosis than 
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Figure 2. Kinetics of cell cycle progression after reversal of a 
mitotic blockade. Parental rat-2 cells (]eft) or derivatives ex- 
pressing relatively low (middle) or high (right) levels of cyclin 
D1 were collected at metaphase (time 0) and released from a 
nocodazole-induced arrest. Cul ures harvested at the indicated 
times after elease of the block were analyzed by flow cytometry 
for DNA content. The channel positions for 2N (G1) and 4N 
(G2/M) cells are noted at the bottom of each column. Cells with 
DNA content between 2N and 4N represent the S-phase popu- 
lation. The numerical distribution of G1, S, and G2/M phase 
fractions for time intervals through 20 hr after release of the 
block is given in Table 2. Peak mitotic indices (determined by 
enumeration of metaphase spreads) for the rat-2, rat-D1 ~~ and 
rat-D1 hi populations were obtained after 20, 18, and 17 hr, re- 
spectively, indicating that the shortened G1 intervals observed 
for cyclin D1 overexpressers t anslated to a shorter overall gen- 
eration time. Rat-2 cells transfected with the naked neo vector 
were indistinguishable from untransfected parental cells. 
parental cells in six independent determinations, even 
though the exact transit imes varied slightly in different 
experiments. Consistent kinetic data were obtained 
when incorporation of BrdU into replicating DNA was 
used to determine the onset of DNA replication (data not 
shown, but see below). The probability that these differ- 
ences were attributable to chance alone is low (P ~< 0.05). 
In three experiments, cyclin D2 also shortened GI- to 
S-phase transit times by -1  hr, but the observed iffer- 
ences may not be significant. 
Cyclins D1 and D2 accelerate Go- to S-phase transit 
in rodent fibroblasts 
We then studied the interval from Go to S phase. Con- 
fluent serum-starved cells in Go were trypsinized and 
replated in medium containing 10% FCS, and their entry 
into S phase was monitored both by incorporation of 
BrdU into replicating DNA or by flow cytometric anal- 
ysis of DNA content. As calculated from flow cytomet- 
ric analyses (Fig. 3A), parental NIH-3T3 cells began to 
enter S phase 12 hr after serum restimulation, whereas 
the derivative cell line overexpressing cyclin D1 initi- 
ated DNA synthesis -2.5 hr faster. Similar data were 
obtained by measurements of BrdU uptake in indepen- 
dent experiments (e.g., see Fig. 4A, below); and in mul- 
tiple determinations, the differences observed between 
overexpressers and vector-transfected control cells were 
highly significant (P ~< 0.05). As judged by enumerating 
metaphases later in the cell cycle, NIH-3T3 cells over- 
expressing cyclin D 1 again exhibited a3-hr shorter mean 
generation time, corresponding to their contracted G1 
intervals. 
Rat-2 cells overexpressing cyclin D 1 (rat-D 1 hi) also ex- 
hibited a 2- to 3-hr shortening of their Go- to S-phase 
transit time (Fig. 3B) and peak mitosis relative to paren- 
tal cells or to those transfected with the control neo vec- 
tor. Here, however, the measurements were complicated 
by the fact that rat-2 cells have a faster generation time 
than NIH-3T3 cells (e.g., cf. Figs. 3B and 4A) and lose 
synchrony more rapidly, so that the maximum percent- 
age of cells in S phase 15.5 hr after serum restimulation 
was only 65%. Even with the parental rat-2 cell line, it 
was evident hat as a many as 20% of cells remained in 
S phase at the time (22 hr) when peak mitosis was ob- 
served. An additional problem was that as many as 15% 
of the cyclin D1 overexpressers remained in cycle when 
deprived of serum, as opposed to <5% of the parental 
rat-2 cells, and these had a DNA content of >2N at the 
start of the experiment. Nonetheless, a comparison of 
the results here (Fig. 3B) with those shown for nocoda- 
zole arrest (Fig. 2) indicates that the Go- to S-phase in- 
tervals for cells overexpressing cyclin D1 were -3  hr 
longer than their respective G1 to S transit imes, reflect- 
ing the additional time required for the cells to reenter 
the cell cycle from quiescence. In multiple determina- 
tions, cyclin D1 overexpression contracted both the Go 
to S (2.2 + 0.8 hr) and G~ to S (2.4 + 0.6 hr) intervals by 
similar extents, suggesting that it did not affect the Go to 
G1 transition. 
Rodent fibroblasts overexpressing cyclin D2 also man- 
ifested a significantly shortened Go- to S-phase interval 
(1.6 + 0.6 hr) with earlier entry into mitosis (-2 hr) rel- 
ative to the parental cells (Fig. 3). The impression that 
cyclin D2 was less potent than D1 in shortening transit 
from Go to S may simply reflect the levels of the over- 
expressed proteins in these cell lines, rather than a bio- 
logical difference between them. The apparently more 
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Table 2. Cell cycle progression after mitotic arrest 
Rat-2 Rat-D 1 lo Rat-D 1hi 
Time 
{hr} G t S G2/M G 1 S G2/M G1 S G2/M 
0 0.3 12.0 87.7 0.4 37.7 61.9 0.1 23.6 76.2 
4.5 80.5 10.9 8.6 85.0 8.8 6.2 85.5 8.5 5.9 
6 81.3 10.9 7.9 84.9 7.5 7.6 79.6 14.5 5.8 
8 86.1 8.5 5.4 76.2 16.5 7.3 70.3 26.2 3.5 
10 83.3 10.8 5.9 67.3 27.7 5.0 56.3 41.7 2.0 
12 71.4 22.8 5.8 55.3 40.8 3.8 47.5 42.8 9.7 
14 52.9 42.4 4.7 38.8 42.5 18.7 35.5 48.9 15.5 
16 35.7 45.2 19.1 44.7 34.1 21.3 38.3 40.7 21.0 
18 40.0 37.0 23.0 48.5 24.8 26.7 50.5 30.9 18.6 
20 63.3 14.7 21.8 63.9 15.9 20.2 71.7 12.8 15.5 
Cells released from nocodazole arrest were allowed to reenter Gu and the fractions of cells in different phases of the cell cycle were 
computed from flow cytometric histograms of DNA content (Fig. 2) using the computer program PEAK (Dean 1980a, b). Untransfected 
rat-2 cells initiated DNA synthesis between 10 and 12 hr after release of the block. Rat-D1 l~ cells began to enter S phase by 8 hr, and 
the rat-D1 hi population initiated DNA replication by 6-8 hr. As expected, peak mitotic indices (determined by enumeration of 
metaphase spreads) for the rat-2, rat-D1 l~ and rat-D1 hi populations were obtained after 20, 18, and 17 hr, respectively, slightly after 
the observed G2/M maxima calculated from flow cytometric analysis. 
limited effect of cyclin D2 on the Go to S interval was 
consistent with results obtained after release of a no- 
codazole block, where its effect versus that of D1 was 
also less obvious. 
Because overexpression f D-type cyclins in fibroblasts 
shortened both their G1 intervals and generation times, 
their effects on the cell cycle distribution of asynchro- 
nously dividing cells are predicted to be relatively small. 
Even in the best case using rat-D1 hi cells, as much as a 
25% contraction of the G1 interval coupled with a pro- 
portionate decrease in total cell generation time (15% 
overall, as confirmed by growth curves) would reduce the 
G1 fraction of asynchronous ly  dividing cycl in D overex- 
pressers only by -8%.  In agreement, an extended series 
of independent flow cytometr ic  measurements  of DNA 
content for asynchronous ly  growing rat-D1 hi overex- 
pressers revealed that their average Gx fraction was re- 
duced by 6 - 3% relative to their parental counterparts. 
It would be antic ipated that  cells exhibit ing a less evi- 
dent contract ion in their G~ interval would be virtual ly 
indist inguishable from their parental counterparts in 
this regard when examined as asynchronous popula- 
tions. 
Cells overexpressing cyclins D1 and D2 manifest 
a reduced serum dependency 
Although rodent fibroblasts overexpressing cyclins D1 
and D2 required serum for G1 progression, it was more 
difficult to arrest cells overexpressing D-type cyclins in 
Go by lowering their serum concentration (see above). To 
study their serum dependence, subconfluent NIH-3T3 
cells were growth arrested for 36 hr in medium contain- 
ing 0.1% FCS and then restimulated with medium con- 
taining different serum concentrations. Using BrdU la- 
beling to quantify DNA synthesis, we observed that pa- 
rental NIH-3T3 cells, as well as those transfected with 
the control neo vector, entered S phase -10.5 hr after 
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Figure 3. Cell cycle progression after serum stimulation of Go- 
arrested cells. NIH-3T3 (A) and rat-2 (B) cell lines and their 
derivatives expressing cyclins D1 or D2 were rendered quies- 
cent by serum starvation and then restimulated toenter the cell 
cycle. The percentages of ceils in S phase for each cell line at 
various times after serum stimulation were calculated from 
flow cytometric measurements of DNA content during the en- 
suing cycle. (A)(O) Parental NIH-3T3 ceils; (O) 3T3-D1; (•) 
3T3-D2. (B)(O) Parental rat-2 cells; (0) rat-Dlhi; (A) rat-D2 hi. 
Entry into mitosis (as determined from enumeration of meta- 
phase spreads) for NIH-3T3, 3T3-D1, and 3T3-D2 were observed 
21, 18, and 19.5 hr, respectively, after serum stimulation. Max- 
imal mitoses were observed for rat-2, rat-D 1 hi, and rat-D2 hi pop- 
ulations after 22, 19, and 19 hr, respectively. Cells transfected 
with the control neo vector behaved indistinguishably from the 
parental cell lines. 
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Figure 4. Serum dependence for S-phase entry. NIH-3T3 cells 
and derivative populations overexpressing D-type cyclins were 
rendered quiescent by starvation in 0.1% serum for 36 hr and 
then restimulated with fresh media containing either 10% (A), 
2% (B), or 0.2% (C) FCS. Entry of cells into S phase was deter- 
mined by incorporation of BrdU, which was added to the cul- 
tures immediately after release from G o. (O) NIH-3T3 cells 
transfected with the control neo vector; ([2) parental NIH-3T3 
cells; (O)3T3-D1; (A)3T3-D2; (A), NIH-3T3 cells cotransfected 
with cyclin D2 plus cdk4. Note the different scales for the ab- 
scissa in B and C vs. A. Although all cells manifested elayed 
entry into S phase after stimulation with 2% serum (B), the 
relative rates of entry for different cell lines were generally 
maintained (of. B and A). Not all cells stimulated with 0.2% 
FCS entered S phase, but a much higher proportion of cyclin D 
overexpressers than control cells were replicating DNA 35--40 
hr after stimulation. 
stimulation with 10% serum (Fig. 4A). Incorporation of 
BrdU into replicating DNA unambiguously identifies 
cells in early S phase by virtue of their nuclear labeling; 
and because this method is somewhat more sensitive 
than measurements of DNA content in scoring the onset 
of DNA replication, it yields reduced values for Go to S 
transit times (e.g., cf. Figs. 4A and 3A). Nonetheless, in 
this experiment, cells overexpressing cyclins D 1 and D2 
again entered S phase -3  hr earlier than parental cells or 
those transfected with the control neo vector. Cells co- 
expressing exogenous cyclin D2 and cdk4 exhibited an 
even faster onset of DNA replication (Fig. 4A), but here, 
we could not distinguish whether the added impetus was 
attributable to ectopic expression of cdk4 or, rather, to 
the synthesis of even higher levels of cyclin D2 (Fig. 1B, 
lane 9) than those in cells transfected with the cyclin 
gene alone (Fig. 1B, lane 6). 
When restimulated with 2% FCS, each of the cell lines 
entered S phase more slowly, but the temporal relation- 
ships between them were maintained (Fig. 4B). As the 
serum concentration was lowered to 0.2%, most of the 
parental cells no longer entered S phase, but a much 
higher proportion of cells overexpressing D-type cyclins 
continued to replicate DNA (Fig. 4C). Analysis of growth 
curves indicated that as the serum concentration was 
decreased, the doubling time for control cells and cyclin 
D overexpressers declined in parallel (data not shown), 
consistent with the data shown in Figure 4. Cells over- 
expressing cyclin D1 or D2 are therefore not oncogeni- 
cally transformed. They remain dependent on serum for 
proliferation, do not form colonies in semisolid medium 
(data not shown), and are contact inhibited, even though 
they exhibit a reduced serum dependency. 
Cells overexpressing cyclins are reduced in size 
Microscopic analysis of confluent cultures suggested 
that cells overexpressing cyclin D1 were smaller than 
parental cells or those transfected with the control neo 
vector, and their apparent saturation density appeared to 
be somewhat higher. When quiescent, contact-inhibited 
cells were trypsinized and single cell suspensions were 
analyzed in a Coulter counter, the modal cell volumes of 
fibroblasts overexpressing cyclin D1 were reduced com- 
pared with their parental counterparts, with rat-2 deriv- 
atives showing greater differences (Fig. 5). Only minimal 
modal size differences between rat-D2 and parental con- 
trol populations were seen, and the corresponding NIH- 
3T3 counterparts were indistinguishable from one an- 
other (for modal cell volumes, see the legend to Fig. 5). 
NIH-3T3 cells overexpressing higher levels of D2 to- 
gether with cdk4 were smaller than controls, but this 
result is again interpreted less easily, given the enforced 
coexpression of the catalytic subunit. Parallel measure- 
ments of asynchronously growing cells yielded similar 
percentage differences in modal size between overex- 
pressers and parents, although the overall volumes of 
growing cells were uniformly larger. Thus, although 
both cyclin D1 and D2 overexpressers exhibited con- 
tracted Go- to S-phase intervals and a reduced serum de- 
pendency, the effects of D2 alone on these parameters 
and on cell size were less dramatic. 
Inhibition of cyclin D1 function inhibits S-phase entry 
Baldin et al. (1993) recently demonstrated that microin- 
jection of antibodies to cyclin D1 into human lung fibro- 
blasts prevented their entry into S phase. Progression of 
cells injected during mid-G1 was inhibited, whereas 
those injected just prior to Gt/S were unaffected and 
initiated DNA synthesis. To verify that rodent fibro- 
blasts or derivatives overexpressing cyclin D1 require 
the protein for G1 progression, cells were made quiescent 
by serum starvation; restimulated with medium con- 
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Figure 5. Volume of confluent cells. Cell lines were grown to 
confluence, trypsinized, and analyzed on a Coulter counter. The 
modal cell volumes (10 -12 liters) were NIH-3T3 (1.3 +-0.14); 
NIH-3T3, neo-resistant (1.17 + 0.06); 3T3-D1 (1.04 + 0.09); 3T3- 
D2 (1.27 -+ 0.17); 3T3-D2/cdk4 (0.95 --- 0.07); rat-2 (1.08 _+ 0.14); 
rat-2, neo-resistant (1.24 _+ 0.14); rat-D1 hi (0.51 -+ 0.08); and rat- 
D2 hi (0.98 +- 0.15). 
sitions has been indirect. First, D-type cyclins are nor- 
mally synthesized uring the delayed early response to 
growth factor stimulation in many cell types (Matsu- 
shime et al. 1991a, b; Cocks et al. 1992; Won et al. 1992; 
Ajchenbaum et al. 1993). In macrophages, cyclin D1 syn- 
thesis is nonperiodic and persists throughout the cell 
cycle as long as colony-stimulating factor 1 is continu- 
ously present; but because both D1 mRNA and protein 
are unstable, its level declines rapidly following prema- 
ture growth factor withdrawal during G~, correlating 
with the failure of cells to enter S phase (Matsushime t 
al. 1991a). Cyclin D1 protein synthesis is regulated sim- 
ilarly in response to serum in fibroblasts. The D-type 
cyclins therefore appear to act as growth factor sensors 
rather than cell cycle-regulated gene products, and on 
this basis, we proposed that they would function during 
the G1 interval. Second, cyclins D1 and D2 are targets of 
chromosomal translocations, gene amplification, and 
retroviral insertional activation in a variety of rodent and 
human tumors (Lammie et al. 1991, 1992; Motokura et 
al. 1991; Rosenberg et al. 1991; Withers et al. 1991; 
Hanna et al. 1993; Jiang et al. 1992; Bianchi et al. 1993), 
suggesting that they act as positive growth regulators. 
Third, the D-type cyclins can physically associate with 
hypophosphorylated forms of the retinoblastoma gene 
product (pRb)(Dowdy et al. 1993; Ewen et al. 1993; Kato 
et al. 1993), a tumor suppressor protein that can prevent 
taining 10% FCS; and at different imes thereafter, were 
microinjected with a purified monoclonal antibody to 
mouse cyclin D1 that does not cross-react with cyclins 
D2 or D3. As a control, parallel cultures were injected 
with an isotype-matched antibody to a T lymphocyte 
cell-surface antigen (CD3) that is not expressed in fibro- 
blasts. BrdU was added to the cells at the time of serum 
stimulation, and its incorporation into DNA was mea- 
sured 20 hr later. Microinjections of cyclin D1 antibody 
into NIH-3T3 cells (Fig. 6A) or rat-2 cells (Fig. 6B) either 
3 or 6 hr after serum stimulation prevented the majority 
from entering Sphase, but injections performed near the 
G1/S-phase boundary were no longer inhibitory. Similar 
results were obtained with cell lines overexpressing cy- 
clin D1, indicating that its G~ accelerating effect could 
be overcome and that S-phase ntry remained ependent 
on its function (Fig. 6). Therefore, cyclin D 1 overexpress- 
ers could not have sustained secondary mutations that 
were themselves responsible for the observed alterations 
in cell cycle phenotype. Because the Go to G~ transition 
in these cells lasts no longer than 3-4 hr (cf. Figs. 2 and 
3), the ability of the cyclin D1 antibody to inhibit 
S-phase entry when injected as late as 6 hr after serum 
stimulation confirms that this cyclin must play a rate- 
limiting function during G~. 
Discussion 
Until recently, evidence to support he putative role of 
D-type cyclins in regulating Gl-specific cell cycle tran- 
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Figure 6. Microinjection of antibodies to cyclin D1 arrests 
S-phase entry. Parental fibroblasts and derivatives overexpress- 
ing cyclin D1 were arrested by serum starvation and restimu- 
lated to enter the cell cycle with medium containing 10% se- 
rum. Cells were microinjected in their cytoplasm either with a 
control antibody to CD3 antigen (-) or with antibody to cyclin 
D1 ( + )at 3, 6, and 10 or 12 hr after serum stimulation. BrdU 
was added to the cells with serum, and its incorporation i to 
replicating DNA was measured after 20 hr. 
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G~ exit (Weinberg 1991). Introduction of cyclin D2 to- 
gether with RB into RB-negative human Saos-2 cells re- 
suits in pRb hyperphosphorylation andabrogates its abil- 
ity to prevent he onset of DNA synthesis (Ewen et al. 
1993), whereas cyclin D1, which overrides pRb function 
less efficiently (Hinds et al. 1992), appears to do so via 
another mechanism (Dowdy et al. 1993). Fourth, disrup- 
tion of cyclin D1 function by microinjection of specific 
antibodies or antisense plasmids into serum-stimulated 
human fibroblasts prevents their entry into S phase (Bal- 
din et al. 1993). Because injections performed during 
mid-G~ phase were inhibitory but those at G~/S were 
not, cyclin D 1 function must be required after the Go to 
G1 transition and before the onset of DNA synthesis. 
As shown here, overexpression f cyclin D 1 in rodent 
fibroblasts can accelerate G~ progression by several 
hours, and these effects could also be reversed by micro- 
injection of specific antibodies to the protein. A contrac- 
tion of the G~ interval was observed in cells exiting mi- 
tosis from a nocodazole-induced block similar to quies- 
cent cells entering G~ phase after serum restimulation, 
consistent with the notion that overexpression f cyclin 
D1 affected G~ to S phase, but not Go to G1 phase, pro- 
gression. In the case where independently derived rat 
fibroblast populations expressing relatively high or low 
levels of cyclin D1 were compared, those expressing 
more of the protein manifested shorter G~ transit and 
correspondingly reduced mean generation times. Be- 
cause overexpressers move more rapidly through the cell 
cycle, only minimal decreases in the G~ fraction were 
observed in asynchronously proliferating populations. 
These cells manifested a reduced serum requirement for 
S-phase ntry and were smaller in size. By use of an in- 
ducible system, others have observed an identical phe- 
notype in rat-1 cells engineered to overexpress cyclin D 1 
(D. Resnitzky and S. Reed, pets. comm.). 
Cells overexpressing cyclin D2 also showed a signifi- 
cantly reduced Go- to S-phase interval following serum 
stimulation and were less serum dependent, but changes 
in cell size were not as evident. NIH-3T3 cells expressing 
exogenous cyclin D2 plus cdk4 entered S phase more 
rapidly from quiescence than those expressing cyclin D2 
alone, but these effects might either be attributed to col- 
laboration between cyclin D2 and the overexpressed cat- 
alytic subunit or to the increased cyclin D2 levels ob- 
served in the doubly transfected cells. Normally, the 
D-type cyclins are differentially expressed in various cell 
lineages, implying that they are not strictly redundant. 
Cyclins D 1 and D2 can exert independent effects on pRb 
function (Dowdy et al. 1993; Ewen et al. 1993) and in- 
teract combinatorially with various cdk partners (Mat- 
sushime t al. 1992; Xiong et al. 1992; Ewen et al. 1993; 
Kato et al. 1993). Although it is unlikely that they func- 
tion equivalently, cyclin D 1 and most likely D2 are rate 
limiting in fibroblasts during G~. 
Several caveats in the interpretation f these findings 
need to be emphasized. First, we were initially unable to 
obtain detectable ectopic overexpression of cyclin D 1 in 
rodent fibroblasts using a series of mammalian retroviral 
vectors that have been widely used to express other 
genes. In these cases, the numbers of G418-resistant col- 
onies obtained after transfection were greatly reduced 
relative to cells transfected with the corresponding neo- 
containing control vectors. Therefore, expression of cy- 
clin D1 from what we assume are stronger promoters 
than the avian RSV LTR might have been toxic to trans- 
fected rodent fibroblasts, pRc/RSV-neo, however, is not 
unique in its ability to confer ectopic cyclin D expres- 
sion, because we have been able to overexpress moderate 
levels of D-type cyclins in rat-2 fibroblasts, mouse my- 
eloid 32Dc13 cells, and BAC1.2F5 mouse macrophages 
using an artificial heavy metal-responsive promoter. 
Transfections utilizing the pRc/RSV-neo vector did not 
reduce the frequency of G418-resistant colonies and gave 
rise to thousands of transformants hat were pooled be- 
fore analysis. We reasoned that such polyclonal cell pop- 
ulations, independently derived from multiple transfec- 
tion experiments with two parental cell lines, would be 
unlikely to have consistently sustained complementing 
mutations that might facilitate cyclin expression or con- 
tribute directly to the phenotypes observed. The ability 
of microinjected antibodies to cyclin D1 to prevent 
S-phase entry in cells overexpressing the protein pro- 
vides further evidence that secondary mutations that by- 
passed cyclin function had not occurred. 
Another concern is that the ability of D-type cyclins to 
alter G1 progression might reflect functional substitu- 
tion for another cyclin that normally plays this role. In 
budding yeast, for example, the enforced expression of 
several mammalian cyclins can complement G1 cyclin 
(CLN) deficiency, and in this system, mammalian Ibut 
not yeast) mitotic cyclins paradoxically proved more ef- 
fective than D-type cyclins in rescue, indicating that cy- 
clin overexpression can result in a loss of specificity 
(Koff et al. 1991; Lew et al. 1991; Xiong et al. 1991). 
Overexpression of cyclin E in rat-1 or human foreskin 
fibroblasts also shortens their G~ interval, decreases cell 
size, and reduces their serum requirement for the G~- to 
S-phase transition IOhtsubo and Roberts 1993), leaving 
open the possibility hat D-type cyclins might override a 
function that is physiologically regulated by cyclin E, or 
vice versa. Whereas the generation time of cyclin E over- 
expressers was unchanged because of a compensatory 
lengthening of S phase (Ohtsubo and Roberts 1993), cells 
overexpressing cyclins D 1 and D2 entered mitosis some- 
what faster. These apparent differences in phenotype are 
probably significant, but cyclins D and E need to be 
tested in parallel with similar vectors and cell lines. 
Overexpression f cyclin D or E does not lead to fibro- 
blast transformation i the sense that the cells remain 
serum dependent, contact inhibited, and unable to form 
colonies in semisolid medium. Preliminary results [D.E. 
Quelle and M.F. Roussel, unpubl.) indicate that cells 
overexpressing cyclin D1 do not form tumors in nude 
mice. Why, then, is cyclin D1, observed to be a frequent 
target of specific gene rearrangements in tumor cells? 
Although the shortening of cell generation time and di- 
minished serum dependency should provide overex- 
pressers with a modest growth advantage, this in itself 
would be unlikely to induce tumor formation in vivo, 
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and other collaborating changes are therefore likely to 
contribute to frank neoplasia. In a different biologic set- 
ting, the propensity of D-type cyclins to promote G1 pro- 
gression might override programs for cell cycle arrest and 
differentiation. Results with growth factor-dependent 
myeloid precursors have now indicated that overexpres- 
sion of cyclins D2 and D3, but not D1, prevent granulo- 
cyte differentiation (J-Y. Kato and C.J. Sherr, in prep.). 
If both cyclins D and E independently control the rate 
of G1 progression through the mammal ian cell cycle, 
they presumably regulate different G1 transitions. In 
general, D-type cyclins appear earlier in the cell cycle 
than cyclin E, and the timing of appearance of the latter 
is periodic and corresponds most closely to the G1/S 
transition (Lew et al. 1991; Dulic et al. 1992; Koff et al. 
1992). Passage through the late G1 restriction point re- 
sults in a reduced growth factor requirement (Pardee 
1989) and, ultimately, the onset of S phase, which occurs 
several hours later. Possibly, the functions of D- and 
E-type cyclins are mechanistically linked in controlling 
sequential events. For example, restriction point control 
and the initiation of DNA synthesis hould involve dis- 
crete decisions, each of which could be rate limiting for 
G1 progression or exit. Perhaps, D-type cyclins act up- 
stream of cyclin E as targets of growth factor-induced 
signals, whereas cyclin E might govern the actual onset 
of DNA replication. Whatever the interpretation, both 
classes of genes appear to be bona fide mammal ian G1 
cyclins that control rate-limiting events during this 
phase of the cell cycle. 
Materials and methods  
Expression vectors and transfection procedures 
Complete coding sequences ofcyclins D1, D2, and D3 and cdk4 
(Matsushime t al. 1991a, b 1992) were excised from plasmids, 
blunt ended with the Klenow fragment of DNA polymerase I, 
ligated to oligonucleotide adaptors, and recloned into mamma- 
lian expression vectors. In pRc/RSV-neo (Invitrogen, San Di- 
ego, CA), inserted cDNAs are driven by the RSV LTR and the 
neo gene by the SV40 early promoter. In pZEN-tkneo (Johnson 
et al. 1989) and COS-MSV-tkneo (Muller et al. 1991), the in- 
serted cDNAs are transcribed from the myeloproliferative sar- 
coma virus or MuLV LTRs, respectively, whereas neo is driven 
by the thymidine kinase (tk) promoter; the plasmid backbone of 
COS--MSV-tkneo contains an SV40 origin, which enables its 
amplification in T antigen-positive COS monkey cells. In 
pBC140 (constructed and provided by Drs. Thomas yon Ruden 
and Erwin Wagner, Institute of Molecular Pathology, Vienna, 
Austria), the orientation of the two transcription units is re- 
versed with neo transcription being controlled by the MuLV 
LTR and the inserted gene being driven by an internal CMV 
promoter. In pZIPneoSV(X)I (Cepko et al. 1984), all transcripts 
arise from the MuLV LTR, with the inserted gene encoded by 
the full genome length mRNA and neo specified by a spliced 
subgenomic transcript. The latter four vector plasmids can gen- 
erate infectious virions when transfected into retroviral pack- 
aging cell lines that encode viral structural proteins in trans. 
Cells were transfected by use of a modified calcium phos- 
phate precipitation technique {Chen and Okayama 1987) with 
20 ~g of input plasmid DNA per dish and were selected for 3 
weeks in complete culture medium with 0.8 mg/ml of G418 
(Geneticin; GIBCO, Grand Island, NY). Several thousand rug- 
resistant colonies from each independent transfection were 
pooled, expanded, and frozen as seed stocks. After 2 months in 
continuous culture, cells were replaced from seed stocks to 
avoid clonal selection. 
Cells and culture conditions 
Mouse NIH-3T3 and rat-2 fibroblasts and their transfected de- 
rivatives were maintained in Dulbecco's modified Eagle me- 
dium {DMEM) supplemented with 10% fetal calf serum (FCS), 2 
mM glutamine, 100 U/ml of penicillin, and 100 ~g/ml of strep- 
tomycin. To assess the rate of cell cycle progression following 
Go arrest, cells grown to confluence were starved in medium 
containing 0.1% FCS for 30-36 hr, and quiescent cells were 
trypsinized and replated in complete medium at subconfluent 
densities. To enrich for mitotically arrested cells, cultures 
seeded at 1 x 106 cells per 150-mm-diam. dish were first starved 
in medium containing 0.1% FCS for 30-36 hr to induce quies- 
cence. Complete medium containing 10% FCS was added to 
bring the cells synchronously into cycle, and incubation was 
continued for 15-17 hr, enabling their entry into late Sand early 
G2 phase (as confirmed by flow cytometric analysis of DNA 
content). Nocodazole (0.07 ~g/ml for rat-2 and 0.4 izg/ml for 
NIH-3T3 cells) was then added for 5 hr, and rounded cells ar- 
rested in mitosis were detached by gentle pipeting. Cells were 
washed free of the drug with phosphate-buffered saline (PBS) 
and replated at subconfluence in complete medium. Cells pro- 
gressing through the cell cycle after reversal of G o or mitotic 
blockades were harvested at the intervals hown in the figures, 
and their positions in the cell cycle were determined. 
Analysis of cell cycle kinetics 
For flow cytometric analysis of DNA content, -1 x 10 6 cells 
were detached from culture dishes by trypsinization, diluted 
1 : 1 in complete medium, and collected by low speed centrif- 
ugation at 23~ The cell pellet was resuspended in a 1-ml so- 
lution of 0.1% sodium citrate and 0.1% Triton X- 100 containing 
50 ~g/ml of propidium iodide and treated with 1 ~g/ml of 
RNase (Calbiochem, San Diego, CA) for 30 min at 23~ Sam- 
ples were filtered through 44-~m nylon mesh immediately be- 
fore analysis by flow cytometry. Fluorescence >570 nm emitted 
from the propidium iodide-DNA complex in each cell nucleus 
was measured with a Coulter EPICS 753 flow cytometer 
{Coulter Electronics, Hialeah, FL), with laser output adjusted to 
deliver 500 mW at 488 nm. Approximately 50,000 cells were 
examined for each sample with a flow rate of 300-500 cells per 
second. The percentages of cells within the G~, S, and G2/M 
phases of the cell cycle were determined by analysis with the 
computer program PEAK (Dean 1980a, b). 
Cell cycle progression into S phase was also monitored by 
incorporation of BrdU into newly synthesized DNA. Synchro- 
nized cells were stimulated to enter the cell cycle in complete 
medium supplemented with 100 ~M BrdU (Sigma Chemicals, 
St. Louis, MO) and plated into 8-well slides at 1 x l0 s cells per 
ml. For detection of BrdU incorporation, cells were washed once 
with PBS, fixed for 5 rain at 4~ with 100% methanol, and 
permeabilized with 0.25% Triton X-100 in PBS for 5 rain at 
room temperature. After two more washes with PBS, cells were 
incubated for 10 min at room temperature in 1.5 M HC1 and 
then washed four more times with PBS. Cells were incubated 
for 30 rain at 37~ in a humidified chamber with mouse mono- 
clonal antibodies to BrdU (1:3 dilution, Oncogene Sciences, 
Manhasset, NY) and, after three PBS washes, with fluorescein- 
conjugated antiserum to mouse immunoglobulin (1:50 dilu- 
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tion; Sigma Chemicals). After washing three times with PBS, 
cells were wet mounted with Permafluor (Lipshaw), and the 
labeled nuclear fractions were enumerated under a fluorescence 
microscope. 
To determine when synchronized cell populations reinitiated 
mitosis, metaphase chromosome spreads were prepared from 
cells harvested at different intervals after release from a G o or 
mitotic block. Approximately 5 x 10  4 cells were collected by 
centrifugation, swollen for 15 min in 1 ml of 0.075 M KC1, and 
0.2 ml of ice-cold Carnoy's solution [3 parts methanol, 1 part 
glacial acetic acid (vol/vol)] was added. Cells were centrifuged, 
resuspended in 0.2 ml of Carnoy's solution ice, and samples 
were pipeted onto a glass slide, blown dry, and stained with 
Giemsa solution. Metaphases per total number of nuclei were 
counted under a light microscope. As expected, maximal mi- 
totic indices in these experiments were achieved -1 hr later 
than peak G2/M levels determined by flow cytometry. 
Cyclin D1 (six experiments) and D2 (six experiments) over- 
expressers always exhibited accelerated entry into S phase from 
G o as compared with parental or vector-transfected control 
ceils. The contraction of the G 0- to S-phase interval was 
2.2 +- 0.8 hr for cyclin D1 and 1.6 +- 0.6 hr for cyclin D2. Al- 
though the exact times of G~ transit varied slightly between 
individual experiments, the probability that the observed iffer- 
ences were attributable to chance alone is ~0.05 (Wilcoxon's 
test and Sign test). In a similar series, cyclin D1 overexpressers 
also showed a reduced G~ to S interval relative to control cells 
(2.4 + 0.6 hr, P ~< 0.05), which was not significantly different 
from the contraction of their Go to S interval. Therefore, we 
have no evidence for a role of cyclin D1 in Go to G1 progression. 
Although cyclin D2 shortened G1 to S (from a nocodazole block) 
by -1 hr, the number of experiments (three) was insufficient to 
conclude that these populations differed significantly from pa- 
rental control cells. 
Other analytical procedures 
The clonality of pooled, neo-resistant populations was assessed 
by Southern blotting analyses of cellular DNAs performed with 
a neo probe. In brief, DNAs were either digested with restriction 
endonucleases that recognize vector DNA sites flanking the neo 
gene or with an enzyme that cuts 5' to neo and releases the gene 
linked to host cellular DNA sequences. In the first instance, a
single neo-containing fragment was observed, whereas in the 
second case, a smear of fragments was detected, which hybrid- 
ized at lower intensity. Therefore, each transfected population 
contained multiple vector integrations and was polyclonal. 
For biosynthetic studies, 1 x 10 6 exponentially growing cells 
were labeled for 1 hr with 0.2 mCi/ml of [3SS]methionine (Am- 
ersham, 800 Ci/mmole) in 1 ml of methionine-free medium 
supplemented with 10% FCS. Labeled cells were lysed for 30 
rain on ice in 1 ml of EBC buffer (50 mM Tris-HC1 at pH 8.0, 120 
mM NaC1, 0.5% NP-40, 1 mM EDTA) containing 5 ~g/ml of 
aprotinin, 5 ~zg/ml of leupeptin, and 1 mM PMSF (protease in- 
hibitors from Sigma Chemicals). Lysates were clarified by cen- 
trifugation, and the cleared supernatants were incubated over- 
night at 4~ with the indicated antibodies. After incubation for 
1 hr at 4~ with protein A-Sepharose b ads, immunoprecipi- 
tates were collected by centrifugation, washed three times in 
EBC buffer at 4~ and denatured in sample buffer for electro- 
phoresis on polyacrylamide slab gels containing SDS as de- 
scribed {Anderson et al. 1984). Samples eparated on 12.5% gels 
were visualized by autoradiography. Immunoblotting analyses 
were performed with rabbit antisera prepared against full-length 
cyclins or cdk4 produced in bacteria (Matsushime t al. 1991a, 
1992). Immunoprecipitated proteins separated on 10% poly- 
acrylamide gels containing SDS were transferred to nitrocellu- 
lose, and blocked filters were immunoblotted with the same 
antisera, followed by detection with 12SI-labeled protein A 
(Downing et al. 1988). 
Microinjection studies and monoclonal antibody 
Rat-2 or NIH-3T3 cells plated at subconfluence onto gridded 
coverslips (Belloc Inc.) were starved for 30 hr in medium con- 
taining 0.1% FCS and then restimulated with complete me- 
dium containing 10% FCS and BrdU. At the indicated times 
thereafter (Fig. 6), cells were microinjected with glass capillaries 
drawn to a tip diameter of <1 ~m as described (Wang et al. 
1982). A control antibody (OKT3) to the T lymphocyte antigen 
CD3 and a purified mouse monoclonal antibody specific for 
cyclin D1 were suspended at 3 mg/ml in 0.5x PBS, and -10-14 
liters of either solution was introduced per cell. Each injected 
area contained 30-50 cells per time point per experiment and 
was identified by grid number. At 20 hr after serum stimulation, 
cells were washed twice with PBS, fixed with acid alcohol {eth- 
anol/acetic acid, 95 : 5) for 20 min at 20~ and BrdU incorpo- 
ration into DNA was measured immunochemically (Amersham 
Cell Proliferation Kit) by use of a monoclonal antibody to BrdU 
and peroxidase-conjugated goat anti-mouse antibodies. The per- 
oxidase substrate consisted of diaminobenzidine, which in the 
presence of cobalt and nickel gave blue-black staining at sites of 
BrdU incorporation. The results shown represent the averages 
of three independent experiments with each cell ine. 
The antibody used here was generated and purified from se- 
rum-free hybridoma culture supernatants using methods imi- 
lar to those described previously (Anderson et al. 1982). The 
monoclonal immunoglobulin G to cyclin D 1 reacts specifically 
with the murine protein but not with its human cognate or with 
mouse cyclins D2 and D3. The antibody is active in immuno- 
precipitation and immunoblotting and is useful for detecting 
cyclin D1 in fixed permeabilized nuclei of mouse cells synthe- 
sizing the protein. 
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